中西医治疗慢性心力衰竭合并抑郁及焦虑状态的研究进展
Research Progress on the Treatment of Chronic Heart Failure Complicated with Depression and Anxiety by Traditional Chinese and Western Medicine
DOI: 10.12677/acm.2026.161025, PDF,   
作者: 王荣婷:黑龙江中医药大学研究生院,黑龙江 哈尔滨;崔健昆*:黑龙江中医药大学附属第一医院心血管病四科,黑龙江 哈尔滨
关键词: 慢性心力衰竭抑郁焦虑研究进展综述Chronic Heart Failure Depression Anxiety Research Progress Review
摘要: 当前慢性心力衰竭与抑郁、焦虑共病率升高,二者互为病理条件,会增加患者死亡风险,已成为临床重点问题。西医发病机制主要与神经激素调节异常及炎症反应相关,中医则以“本虚标实”为核心病机。临床形成西医、中医药及非药物干预的协同治疗格局,中西结合协同治疗疗效可观。本文系统梳理慢性心力衰竭合并抑郁及焦虑状态的发病机制、治疗策略及研究进展,以期为临床治疗提供理论与实践参考。
Abstract: Currently, the comorbidity rate of chronic heart failure (CHF) with depression and anxiety is increasing. These conditions interact as pathological factors, elevating patient mortality risk, and have become a key clinical concern. The pathogenesis in Western medicine is primarily associated with neurohormonal dysregulation and inflammatory responses, while Traditional Chinese Medicine (TCM) identifies “deficiency-root and excess-superficiality” as the core pathogenesis. A collaborative treatment landscape integrating Western medicine, TCM therapies, and non-pharmacological interventions has been established in clinical practice, with integrated Traditional Chinese and Western medicine demonstrating considerable therapeutic efficacy. This article systematically reviews the pathogenesis, treatment strategies, and research progress regarding CHF complicated with depression and anxiety, aiming to provide theoretical and practical references for clinical management.
文章引用:王荣婷, 崔健昆. 中西医治疗慢性心力衰竭合并抑郁及焦虑状态的研究进展[J]. 临床医学进展, 2026, 16(1): 180-185. https://doi.org/10.12677/acm.2026.161025

参考文献

[1] 朱明军, 张健, 毛静远. 射血分数保留的心力衰竭中西医结合诊疗专家共识[J]. 中医杂志, 2025, 66(8): 860-872.
[2] Norman, J.F., Kupzyk, K.A., Artinian, N.T., Keteyian, S.J., Alonso, W.S., Bills, S.E., et al. (2019) The Influence of the HEART Camp Intervention on Physical Function, Health-Related Quality of Life, Depression, Anxiety and Fatigue in Patients with Heart Failure. European Journal of Cardiovascular Nursing, 19, 64-73. [Google Scholar] [CrossRef] [PubMed]
[3] 胡大一. 心血管疾病和精神心理障碍的综合管理——“双心医学”模式的探索[J]. 中国临床医生, 2006(5): 2-3.
[4] 徐晓青, 陈晓虎. 陈晓虎从“气、郁、瘀”论治慢性心力衰竭伴焦虑抑郁经验[J]. 基层中医药, 2024, 3(3): 16-20.
[5] 高敏, 胡丹丽, 邢福威, 等. 心力衰竭患者抑郁及其与一年结局的相关性分析[J]. 中国循环杂志, 2021, 36(6): 606-611.
[6] 中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中国医师协会心力衰竭专业委员会, 等. 中国心力衰竭诊断和治疗指南2024 [J]. 中华心血管病杂志, 2024, 52(3): 235-275.
[7] Belvederi Murri, M., Pariante, C., Mondelli, V., Masotti, M., Atti, A.R., Mellacqua, Z., et al. (2014) HPA Axis and Aging in Depression: Systematic Review and Meta-Analysis. Psychoneuroendocrinology, 41, 46-62. [Google Scholar] [CrossRef] [PubMed]
[8] 朱铮, 蒋燕升, 魏黎刚. 焦虑症患者血清IL-1β、IL-6、IL-10水平分析[J]. 国际精神病学杂志, 2019, 46(3): 425-427, 434.
[9] Ovsenik, A., Podbregar, M. and Fabjan, A. (2021) Cerebral Blood Flow Impairment and Cognitive Decline in Heart Failure. Brain and Behavior, 11, e02176. [Google Scholar] [CrossRef] [PubMed]
[10] Celano, C.M., Villegas, A.C., Albanese, A.M., Gaggin, H.K. and Huffman, J.C. (2018) Depression and Anxiety in Heart Failure: A Review. Harvard Review of Psychiatry, 26, 175-184. [Google Scholar] [CrossRef] [PubMed]
[11] Coelho, R., Ramos, S., Prata, J., Bettencourt, P., Ferreira, A. and Cerqueira-Gomes, M. (2005) Heart Failure and Health Related Quality of Life. Clinical Practice and Epidemiology in Mental Health, 1, 19. [Google Scholar] [CrossRef] [PubMed]
[12] 李睿一, 赵海滨. 基于少阴、少阳枢机理论探讨双心疾病证治思路[J]. 中西医结合心脑血管病杂志, 2024, 22(9): 1700-1703.
[13] 唐卓然, 邵正斌, 梁国庆, 等. 慢性心力衰竭合并抑郁病机探微[J]. 长春中医药大学学报, 2025, 41(3): 247-250.
[14] 谭朵廷, 廉坤, 梁昊, 等. 基于少阳枢机理论探讨慢性心力衰竭伴焦虑抑郁病机及柴胡类方的作用机制[J]. 中国实验方剂学杂志, 2025, 31(16): 156-164.
[15] 张赤道, 王永霞, 朱明军, 等. 1973-2023年慢性心力衰竭中医证候特征演变规律文献研究[J]. 世界科学技术-中医药现代化, 2025, 27(1): 121-131.
[16] 蒲瑞. 慢性心力衰竭合并焦虑抑郁状态的中医证候特征研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2024.
[17] 林晓忠, 吴焕林, 严夏, 等. 邓铁涛运用调脾护心法治疗冠心病经验[J]. 中医杂志, 2002(6): 415-416.
[18] 董国菊. 基于“心肺相关”探讨射血分数保留心力衰竭的“心肺同治” [J]. 中国中西医结合杂志, 2023, 43(11): 1371-1374.
[19] 任川明, 曹启洪. 曹启洪主任中医师辨治慢性心力衰竭的学术思想精要[J]. 中国中医急症, 2022, 31(9): 1465-1466+1480.
[20] 唐梅, 李向平. 抗抑郁药的不良反应及其在心血管病患者中的应用[J]. 中南大学学报(医学版), 2020, 45(10): 1228-1233.
[21] Roose, S.P., et al. (1998) Comparison of Paroxetine and Nortriptyline in Depressed Patients with Ischemic Heart Disease. JAMA, 279, 287-291. [Google Scholar] [CrossRef] [PubMed]
[22] Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction. New England Journal of Medicine, 321, 406-412. [Google Scholar] [CrossRef] [PubMed]
[23] Teply, R.M., Packard, K.A., White, N.D., Hilleman, D.E. and DiNicolantonio, J.J. (2016) Treatment of Depression in Patients with Concomitant Cardiac Disease. Progress in Cardiovascular Diseases, 58, 514-528. [Google Scholar] [CrossRef] [PubMed]
[24] 杨凯, 刘宇. 艾司西酞普兰治疗慢性心力衰竭合并抑郁伴或不伴焦虑的临床观察[J]. 中国药房, 2015, 26(12): 1632-1634.
[25] 黄春辉, 张伟, 郑永宏, 等. 沙库巴曲缬沙坦钠片对老年慢性心力衰竭伴焦虑抑郁病人心功能及神经递质指标的影响[J]. 实用老年医学, 2025, 39(8): 793-797.
[26] 刘亚贤, 何茂锐, 张靖. 老年慢性心力衰竭合并焦虑及抑郁障碍心理干预疗效观察[J]. 宁夏医学杂志, 2023, 45(8): 736-738.
[27] Jesulola, E., Micalos, P. and Baguley, I.J. (2018) Understanding the Pathophysiology of Depression: From Monoamines to the Neurogenesis Hypothesis Model—Are We There Yet? Behavioural Brain Research, 341, 79-90. [Google Scholar] [CrossRef] [PubMed]
[28] 聂文鹏, 张媛媛, 杨宏博, 等. 中西医结合治疗慢性心力衰竭合并焦虑和(或)抑郁疗效及安全性的meta分析[J]. 中医研究, 2023, 36(12): 65-74.
[29] 邹伟, 陈明月, 梁丹, 等. 基于CiteSpace探讨黄连温胆汤的研究现状与发展趋势[J]. 医学信息, 2023, 36(13): 8-13.
[30] 顾健霞, 齐彦, 阮娟娟. 慢性心力衰竭合并焦虑抑郁调查及中医药干预的临床疗效[J]. 中医药临床杂志, 2014, 26(8): 790-792.
[31] 丁涵, 李子业, 王倩, 等. 黄精皂苷类成分药理作用及机制研究进展[J/OL]. 中国药理学通报, 1-12.
https://link.cnki.net/urlid/34.1086.R.20251110.1502.005, 2025-11-28.
[32] 梁锦标, 陶锴, 廖萍. 正念减压联合艾司西酞普兰对慢性心力衰竭伴焦虑抑郁患者的影响[J]. 中国医学创新, 2025, 22(27): 174-178.
[33] 丁华, 李朝凤, 程钰, 等. 正念冥想疗法对慢性心力衰竭患者负性情绪及心功能影响的Meta分析[J]. 现代医学, 2024, 52(1): 1-9.
[34] 周苹苹. 放松疗法对老年慢性心力衰竭合并糖尿病焦虑抑郁患者的影响[J]. 糖尿病新世界, 2021, 24(3): 118-120.
[35] 潘琳, 刘英华, 邓露双. 子午流注择时五行音乐疗法联合茯神安眠贴对慢性心力衰竭患者心理状态及睡眠质量的影响[J]. 中国医学创新, 2023, 20(29): 107-111.
[36] 姜曼. 慢性心力衰竭患者心理状态与影响因素以及主要不良心血管事件的短期预测价值[D]: [硕士学位论文]. 锦州: 锦州医科大学, 2024.